Literature DB >> 196180

Activation of rat erythrocyte phosphofructokinase by AMP and by non-physiological concentrations of cyclic AMP.

M Pinilla, J Luque.   

Abstract

Cyclic AMP (300 micron) activates phosphofructokinase from dialyzed haemolysates of mature rat erythrocytes. The main conclusions are: a) Cyclic AMP, at pH 7.1 and low concentrations of fructose-6-phosphate, is able to reverse the inhibition produced by different amounts of ATP (up to 1.5 mM). b) The cyclic nucleotide is a positive allosteric effector of the enzyme as shown by the displacement of sigmoidal fructose-6-phosphate saturation curve to hyperbolic kinetics in the presence of inhibitory concentrations (1.5 mM) of ATP.c) Cyclic AMP has no significant influence as deinhibitor of phosphofructokinase either at pH 7.1 and non-inhibitory levels (0.25 mM) of ATP or at pH 8.1 and inhibitory (1.5 mM) or non-inhibitory (0.25 mM) concentrations of ATP. Similar conclusions were obtained with 300 micron AMP but not at a lower concentration (3 micron) with both nucleotides. The comparison of cyclic AMP result with those obtained under similar concentrations of AMP suggest that cyclic AMP is really only an "in vitro" modulator of the enzyme from rat erythrocytes, presumably at an AMP regulatory stie, since non-physiological concentrations are required to act as deinhibitor.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 196180     DOI: 10.1007/bf01734111

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  11 in total

1.  Evidence for different oligomeric forms of human erythrocyte phosphofructokinase.

Authors:  K -W. Wenzel; G Zimmermann; J Gauer; W Diezel; S Liebe; E Hofmann
Journal:  FEBS Lett       Date:  1972-01-01       Impact factor: 4.124

2.  Phosphofructokinase from human erythrocytes.

Authors:  R B Layzer
Journal:  Methods Enzymol       Date:  1975       Impact factor: 1.600

3.  Standardization of hemoglobinometry. II. The hemiglobincyanide method.

Authors:  E van KAMPEN; W G ZIJLSTRA
Journal:  Clin Chim Acta       Date:  1961-07       Impact factor: 3.786

Review 4.  The significance of phosphofructokinase to the regulation of carbohydrate metabolism.

Authors:  E Hofmann
Journal:  Rev Physiol Biochem Pharmacol       Date:  1976       Impact factor: 5.545

5.  Cooperativity in human erythrocyte phosphofructokinase.

Authors:  L M Lee; R M Krupka; R A Cook
Journal:  Biochemistry       Date:  1973-08-28       Impact factor: 3.162

6.  Adenyl cyclase activity in non-nucleated red blood cells: evidence for its localization in the reticulocytes.

Authors:  K Quiring; D Gauger; G Kaiser; D Palm
Journal:  Experientia       Date:  1973-05-15

7.  Human erythrocyte phosphofructokinase: its purification and some properties.

Authors:  G E Staal; J F Koster; C J Bänziger; L van Milligen-Boersma
Journal:  Biochim Biophys Acta       Date:  1972-07-13

8.  The role of phosphofructokinase in metabolic regulation.

Authors:  J V Passonneau; O H Lowry
Journal:  Adv Enzyme Regul       Date:  1964

9.  Interaction between energy charge and metabolite modulation in the regulation of enzymes of amphibolic sequences. Phosphofructokinase and pyruvate dehydrogenase.

Authors:  L C Shen; L Fall; G M Walton; D E Atkinson
Journal:  Biochemistry       Date:  1968-11       Impact factor: 3.162

10.  Adenyl cyclase in non-nucleated erythrocytes of several mammalian species.

Authors:  H Sheppard; C Burghardt
Journal:  Biochem Pharmacol       Date:  1969-10       Impact factor: 5.858

View more
  2 in total

1.  Uncharged tRNA-phosphofructokinase interaction in amino acid deficiency.

Authors:  M Rabinovitz
Journal:  Amino Acids       Date:  1996-06       Impact factor: 3.520

2.  Changes in glycolytic enzyme activities in aging erythrocytes fractionated by counter-current distribution in aqueous polymer two-phase systems.

Authors:  P Jimeno; A I Garcia-Perez; J Luque; M Pinilla
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.